Abstract
DESIGN. Retrospective analysis
PURPOSE. Macular oedema is not directly visible on two dimensional digital photographs such that surrogate markers need to be used. In the English National Screening Programme these are exudate within one optic disc diameter (DD) of the fovea, group of exudates within two DD of the fovea and haemorrhages or microaneurysms (HMA) within one DD of the fovea with best corrected visual acuity (VA) worse than 6/9. All patients who present with any of these surrogate markers at screening are referred to an ophthalmology clinic for slit lamp examination. The purpose of this audit was to determine how many patients with positive maculopathy diagnosis on photography were truly identified by optical coherence tomography (OCT) with macular oedema.
METHODS. Data was collected from patients attending digital diabetic retinopathy screening. Patients who presented with surrogate markers for macular oedema also had an OCT scan. The fast macula scan on the Stratus OCT was used and an ophthalmologist reviewed the scans to determine whether macular oedema was present.
RESULTS. Maculopathy by exudates: Of 155 patients 45 (29%) showed thickening on the OCT of these 12 required laser. Those who also had pre-proliferative retinopathy (n=20) were more likely to have macular oedema (75%) than those with background diabetic retinopathy.
Maculopathy by HMA and VA worse than 6/9: Of 66 patients 11 (16.7%) showed thickening on the OCT. 5 (7.6%) of these had macular oedema, 5 (7.6%) epi-retinal membrane, and 1 (1.5%) age related macular degeneration. None of these patients required laser.
CONCLUSIONS. The likelihood of the presence of macular oedema and requiring laser treatment is greater with macular exudation than HMA within one DD and reduced VA. Overall the surrogate markers used show low specificity for macular oedema, however combining OCT with photography does identify those with macular oedema who require a true referral for an ophthalmological slit lamp examination.
PURPOSE. Macular oedema is not directly visible on two dimensional digital photographs such that surrogate markers need to be used. In the English National Screening Programme these are exudate within one optic disc diameter (DD) of the fovea, group of exudates within two DD of the fovea and haemorrhages or microaneurysms (HMA) within one DD of the fovea with best corrected visual acuity (VA) worse than 6/9. All patients who present with any of these surrogate markers at screening are referred to an ophthalmology clinic for slit lamp examination. The purpose of this audit was to determine how many patients with positive maculopathy diagnosis on photography were truly identified by optical coherence tomography (OCT) with macular oedema.
METHODS. Data was collected from patients attending digital diabetic retinopathy screening. Patients who presented with surrogate markers for macular oedema also had an OCT scan. The fast macula scan on the Stratus OCT was used and an ophthalmologist reviewed the scans to determine whether macular oedema was present.
RESULTS. Maculopathy by exudates: Of 155 patients 45 (29%) showed thickening on the OCT of these 12 required laser. Those who also had pre-proliferative retinopathy (n=20) were more likely to have macular oedema (75%) than those with background diabetic retinopathy.
Maculopathy by HMA and VA worse than 6/9: Of 66 patients 11 (16.7%) showed thickening on the OCT. 5 (7.6%) of these had macular oedema, 5 (7.6%) epi-retinal membrane, and 1 (1.5%) age related macular degeneration. None of these patients required laser.
CONCLUSIONS. The likelihood of the presence of macular oedema and requiring laser treatment is greater with macular exudation than HMA within one DD and reduced VA. Overall the surrogate markers used show low specificity for macular oedema, however combining OCT with photography does identify those with macular oedema who require a true referral for an ophthalmological slit lamp examination.
| Original language | English |
|---|---|
| Pages (from-to) | 348 |
| Number of pages | 1 |
| Journal | European Journal of Ophthalmology |
| Volume | 21 |
| Issue number | 3 |
| Publication status | Published - 15 Apr 2011 |
| Event | 21st Meeting of the European Association for the Study of Diabetes Eye Complications Study Group (EASDec) - Gdansk, Poland Duration: 13 May 2011 → 15 May 2011 |
Bibliographical note
Abstracts of the 21st Meeting of the European Association for the Study of Diabetes Eye Complications Study Group (EASDEc)Fingerprint
Dive into the research topics of 'How accurate are photographic surrogate markers used to detect macular edema in the English national screening programme?'. Together they form a unique fingerprint.Research output
- 2 Conference abstract
-
Management and outcome of cholesterol embolus identified in a diabetic retinopathy screening program
Whitehouse, K. & Dodson, P. M., 15 Apr 2011, In: European Journal of Ophthalmology. 21, 3, p. 350-351 2 p.Research output: Contribution to journal › Conference abstract › peer-review
-
Proliferative diabetic retinopathy (R3) referrals from the digital diabetic retinopathy screening program: urgency of appointment in the hospital eye service achieved and needed?
Geletew, T. K., Amrelia, P. M., Wharton, H. M., Dodson, P. M., Gibson, J. M. & Wright, A., 15 Apr 2011, In: European Journal of Ophthalmology. 21, 3, p. 348 1 p.Research output: Contribution to journal › Conference abstract › peer-review
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver